No matter the therapeutic area, device companies agree: Creating cutting-edge products is expensive. From the R&D costs to the pricy FDA fees, the expense for innovation adds up quickly. As products become more technologically advanced, the cost for designing new devices has increased. At the same time, device companies are being hit with fees that are wiping out their R&D budgets, such as the 2.3% medical device tax, which reportedly requires companies to collectively pay an estimated $194 million per month.

In an article written by Jamie Hartford and published in in MDDI, indicates that new EU medical regulations are expected to be finalized this year or next.  In an earlier blog, we wrote on the pending regulations and the impact it might have on the medical device industry.